Anzeige
Erschienen in:
01.04.2014 | Topic Paper
A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA)
Erschienen in: World Journal of Urology | Ausgabe 2/2014
Einloggen, um Zugang zu erhaltenAbstract
Purpose
(1) To describe the minimally invasive adjustable continence therapy (ACT)® balloon placement surgical technique. (2) To analyse the results of ACT® balloon in the treatment for female stress urinary incontinence (SUI).
Method
A review of the literature was performed by searching the PubMed database using the following search terms: ACT balloons, female urinary incontinence, and female continence.
Results
Eight studies were published between 2007 and 2013. The mean follow-up of these studies was 1–6 years. The mean age of the patients ranged between 62 and 73 years; 40–100 % of patients had already been treated surgically for their SUI. A significant reduction in the number of pads used per day was observed after ACT® balloon placement, with improvement of short pad tests from 49.6 to 77.3 g preoperatively to 11.2–25.7 g after ACT® balloon placement. Fifteen to 44 % of patients considered that their SUI had been cured and 66–78.4 % were satisfied with the result. The explantation rate ranged between 18.7 and 30.8 %. Quality of life was significantly improved, and no major complication was reported.
Conclusion
ACT® balloons constitute a reasonable, minimally invasive alternative for the treatment for female SUI due to intrinsic sphincter disorder, especially in patients who have already experienced failure of standard surgical treatment and in clinical settings incompatible with invasive surgical placement of an artificial urinary sphincter (especially women over the age of 80 years). Long-term results are essential to evaluate the efficacy of this treatment.